The 4q27 locus and prostate cancer risk

Area of Science:

• Genetics
• Oncology
• Immunology

Background:

• Chronic inflammation is linked to prostate cancer development.
• The chromosome 4q27 region contains immune-related genes IL-2 and IL-21.
• Investigating genetic variants in this region may reveal prostate cancer risk factors.

Purpose of the Study:

• To examine the association between specific genetic variants on chromosome 4q27 and prostate cancer risk.
• To explore potential links between autoimmune-associated variants and prostate cancer susceptibility.

Main Methods:

• Genotyping of seven variants (six autoimmune-associated, one IL-2 promoter) in the Australian Risk Factors for Prostate Cancer case-control study.
• Statistical analysis to determine odds ratios and significance for each variant's association with prostate cancer.

Main Results:

• No significant overall association was found between the seven variants and prostate cancer risk.
• Suggestive evidence indicated an association between the rs13119723 variant and increased prostate cancer risk in men with a family history.
• The rs13119723 variant showed a significantly higher per-allele odds ratio (2.37) in men with a family history.

Conclusions:

• Genetic variation at the 4q27 locus may contribute to prostate cancer susceptibility, particularly in familial cases.
• The protein KIAA1109, encoded by a gene in this region, may play a role in prostate cancer risk.